Ownership

Todd Franklin Watanabe - Reporting Person's title: President and Chief Executive Officer, Director at Arcutis Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Reporting Person's title: President and Chief Executive Officer, Director
Stock Symbol: ARQT on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Todd Franklin Watanabe - trading volume in the past year for Arcutis Biotherapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+6.04K	5.4%	$3.52	+$21.3K
Sells	-106K	94.6%	$11.82	-$1.26M
Net	-100K	-89.3%		-$1.24M

Holdings reported by Todd Franklin Watanabe for Arcutis Biotherapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	925K	$16.3M	$17.56	Mar 25, 2025	Direct
Common Stock	125K	$2.19M	$17.56	Mar 24, 2025	By Trust
Common Stock	57.4K	$1.01M	$17.56	Mar 24, 2025	By LLC
Stock Option (right to buy)	396K			Feb 28, 2025	Direct	Common Stock

Transactions reported by Todd Franklin Watanabe for Arcutis Biotherapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.